AFRIMS Armed Forces Research Institute of Medical Sciences
  • About AFRIMS
  • News
  • Publications
  • Locations / Facilities
  • Contact Us
Left navigator bar NewComer Information Check E-mail Hman Subjects Protection Information Management Resource Management Research Support Logistics Library Epidemiology and Disease Surveillance Human Resources Veterinary Medicine Virology Embassy of the United States, Bangkok Retrovirology JUSMAG Immunology Entomology Enteric Diseases AKO (Army Knowledge Online) D.D.A. D.D.S. RTA-AFRIMS WHO Collaborating Center Director WRAIR iSalute
Our Mission Immunology News Immunology History Our Values Immunology Our Approach Immunology our assets Immunology Research

Our Mission

The Department of Immunology and Medicine's missions are to support medical product development to protect the war fighter, and conduct surveillance of diseases of military importance in SE Asia. Our focus on diseases of relevance to the public health means that our mission is integrated with the public health efforts of our host nation partners.

Our Sponsors include

  1. Organizations within the US Army Medical Research and Materiel Command
  2. Other Department of Defense and US Government Organizations
  3. Extramural Collaborators – host nation governments, NGOs, industry and academia

Key elements of our mission include:

A. Antimalarial product development

  1. Drugs: we seek new drugs to prevent malaria. There is very little development of new drugs for prevention currently, and resistance threatens existing drugs
  2. Vaccines: we seek to develop vaccines to protect against P. falciparum and P. vivax.

B. Disease Surveillance. Our public health surveillance efforts focus on:

  1. Antimalarial drug resistance
  2. Influenza surveillance
  3. Surveillance for other pathogens causing influenza-like illness (ILI)
  4. Leptospirosis
  5. Emerging infectious disease
The US Army is currently developing the following products for FDA licensure.
  1. GMP-formulated intravenous artesunate for severe malaria
    http://www.usammda.army.mil/pharmaceutical.html
  2. Tafenoquine for weekly antimalarial chemoprophylaxis
  3. A malaria vaccine. The US Army helped discover and develop the RTS,S vaccine, and has tested numerous candidates in recent years.
    http://www.wrair.army.mil/ReAndDevelop_InfectDisRe_MalariaResearch.aspx

| Our Mission | News | History | Our Values | Our Approach | Our Assets | Our Research |

Back to AFRIMS main page

Recent Activities at AFRIMS
AFRIMS recent activities HIV Vaccine Study First to show effectiveness AFRIMS on Dengue at Voice of America AFRIMS on Malaria in New York Times AFRIMS researchers instructed 104 medical cadets from Phramongkutklao College of Medicine AFRIMS hosts infectious diseae surveillance workshop for laos PDR lab technicians AFRIMS concludes Pilat Malaria Prophylaxis clinical trial in Cambodia Dr. Rampa Rattanarathiul received the Belkin Award, The highest honor given by the AMCA Dedication and opening of joint AFPMC AFRIMS molecular laboratory in the Phillippines NBC shows story on drug resistant malaria on the Thai-Cambodia border in Cambodia Malaria Vaccine: Inside look at first human trial from BBC news HVRC opening ceremony Change of Command 2015 AFRIMS leaders join "Bike For Mom 2015" event US Embassy Employee of the Month Public Release of Joint Concept of Health Services Public Release of Joint Concept of Health Services more AFRIMS activities

Search AFRIMS